Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Molecular Cancer Therapeutics
|
August 1, 2012
REST is a novel prognostic factor and therapeutic target for medulloblastoma
Pete Taylor, Jason Fangusaro, Veena Rajaram, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 25, 2015
Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival
Bree R Eaton, Natia Esiashvili, Sungjin Kim, et al.
Pediatric Neurology
|
May 19, 2007
Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas
Dusica Babovic-Vuksanovic, Brigitte C Widemann, Eva Dombi, et al.
Journal of Neuro-Oncology
|
August 22, 2018
Rapid discrimination of pediatric brain tumors by mass spectrometry imaging
Amanda R Clark, David Calligaris, Michael S Regan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2010
Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018
Katherine E Warren, Stewart Goldman, Ian F Pollack, et al.
Cancer Cell
|
October 18, 2005
Radial glia cells are candidate stem cells of ependymoma
Michael D Taylor, Helen Poppleton, Christine Fuller, et al.
Journal of Neuro-Oncology
|
October 13, 2006
Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme
Christopher D Turner, Susan Chi, Karen J Marcus, et al.
Pediatric Blood & Cancer
|
December 10, 2008
Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors
Mark W Kieran, Jeffrey G Supko, Dana Wallace, et al.
Scientific Reports
|
May 19, 2023
YB1 modulates the DNA damage response in medulloblastoma
Leon F McSwain, Claire E Pillsbury, Ramona Haji-Seyed-Javadi, et al.
Scientific Reports
|
June 15, 2023
Author Correction: YB1 modulates the DNA damage response in medulloblastoma
Leon F McSwain, Claire E Pillsbury, Ramona Haji-Seyed-Javadi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Molecular Cancer Therapeutics
|
August 1, 2012
REST is a novel prognostic factor and therapeutic target for medulloblastoma
Pete Taylor, Jason Fangusaro, Veena Rajaram, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 25, 2015
Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival
Bree R Eaton, Natia Esiashvili, Sungjin Kim, et al.
Pediatric Neurology
|
May 19, 2007
Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas
Dusica Babovic-Vuksanovic, Brigitte C Widemann, Eva Dombi, et al.
Journal of Neuro-Oncology
|
August 22, 2018
Rapid discrimination of pediatric brain tumors by mass spectrometry imaging
Amanda R Clark, David Calligaris, Michael S Regan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2010
Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018
Katherine E Warren, Stewart Goldman, Ian F Pollack, et al.
Cancer Cell
|
October 18, 2005
Radial glia cells are candidate stem cells of ependymoma
Michael D Taylor, Helen Poppleton, Christine Fuller, et al.
Journal of Neuro-Oncology
|
October 13, 2006
Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme
Christopher D Turner, Susan Chi, Karen J Marcus, et al.
Pediatric Blood & Cancer
|
December 10, 2008
Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors
Mark W Kieran, Jeffrey G Supko, Dana Wallace, et al.
Scientific Reports
|
May 19, 2023
YB1 modulates the DNA damage response in medulloblastoma
Leon F McSwain, Claire E Pillsbury, Ramona Haji-Seyed-Javadi, et al.
Scientific Reports
|
June 15, 2023
Author Correction: YB1 modulates the DNA damage response in medulloblastoma
Leon F McSwain, Claire E Pillsbury, Ramona Haji-Seyed-Javadi, et al.
Page
of 3